Tripeptide and tetrapeptide esters which inhibit gastric secreti

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530331, A61K 3743, C07K 508

Patent

active

046877592

ABSTRACT:
The invention relates to the peptides of the formula: ##STR1## in which: R represents hydrogen or a protecting group for the terminal amine group, such as t-butoxycarbonyl (Boc), benzyloxycarbonyl (Z) or lower alkanoyl;

REFERENCES:
patent: 3875137 (1975-04-01), Jones et al.
patent: 3896103 (1975-07-01), Hardy et al.
patent: 4012367 (1977-03-01), Mazur
patent: 4172130 (1979-10-01), Kisfaludy et al.
patent: 4530837 (1985-07-01), Charon et al.
Journal of Chemistry, vol. 28, No. 3, Mar. 11, 1985.
Chemical Abstracts, vol. 94, No. 9, Mar. 1981.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Tripeptide and tetrapeptide esters which inhibit gastric secreti does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tripeptide and tetrapeptide esters which inhibit gastric secreti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tripeptide and tetrapeptide esters which inhibit gastric secreti will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1117964

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.